ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical CDMO and Contract Manufacturing Services Market Research Report 2025
Published Date: 2025-05-06
|
Report Code: QYRE-Auto-3W16489
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical CDMO and Contract Manufacturing Services Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical CDMO and Contract Manufacturing Services Market Research Report 2025

Code: QYRE-Auto-3W16489
Report
2025-05-06
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Haixiang Pharmaceutical
Innovent Biologics
Betta Pharmaceuticals
Jiuzhou Pharmaceutical
Puluo Pharmaceutical
Menohua
Tianyu shares
Aoxiang Pharmaceutical
Hetero
CELLMARK
R&D Systems
Porton Pharmaceuticals
Kai Laiying
Smart Life
Notai Biotech
Aurobindo Pharma
Catalent
Recipharm
Jubilant Pharmova Ltd.
Patheon Inc. (Thermo Fisher Scientific Inc.)
Boehringer Ingelheim group
Pfizer CentreSource
Baxter International Inc

Pharmaceutical CDMO and Contract Manufacturing Services Market

The global market for Pharmaceutical CDMO and Contract Manufacturing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
In order to reduce drug R&D costs and improve production efficiency, pharmaceutical company customers entrust pharmaceutical process R&D and production to customized companies. The company accepts the entrustment of multinational pharmaceutical companies to provide pharmaceutical process research and development and drug production services, which are CDMO services.
North American market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical CDMO and Contract Manufacturing Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Pharmaceutical CDMO and Contract Manufacturing Services in Pharma Industry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Pharmaceutical CDMO and Contract Manufacturing Services include Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical, Hetero, CellMark, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CDMO and Contract Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CDMO and Contract Manufacturing Services.
The Pharmaceutical CDMO and Contract Manufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical CDMO and Contract Manufacturing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical CDMO and Contract Manufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical CDMO and Contract Manufacturing Services Market Report

Report Metric Details
Report Name Pharmaceutical CDMO and Contract Manufacturing Services Market
Segment by Type
  • Drug Development
  • API production
Segment by Application
  • Pharma Industry
  • Biotechnology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical, Hetero, CellMark, R&D Systems, Porton Pharmaceuticals, Kai Laiying, Smart Life, Notai Biotech, Aurobindo Pharma, Lonza Group, Catalent Inc., Recipharm AB, Jubilant Pharmova Ltd, Patheon Inc. (Thermo Fisher Scientific Inc.), Boehringer Ingelheim Group, Pfizer CentreSource, Baxter International Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical CDMO and Contract Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical CDMO and Contract Manufacturing Services Market report?

Ans: The main players in the Pharmaceutical CDMO and Contract Manufacturing Services Market are Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Menohua, Tianyu shares, Aoxiang Pharmaceutical, Hetero, CellMark, R&D Systems, Porton Pharmaceuticals, Kai Laiying, Smart Life, Notai Biotech, Aurobindo Pharma, Lonza Group, Catalent Inc., Recipharm AB, Jubilant Pharmova Ltd, Patheon Inc. (Thermo Fisher Scientific Inc.), Boehringer Ingelheim Group, Pfizer CentreSource, Baxter International Inc.

What are the Application segmentation covered in the Pharmaceutical CDMO and Contract Manufacturing Services Market report?

Ans: The Applications covered in the Pharmaceutical CDMO and Contract Manufacturing Services Market report are Pharma Industry, Biotechnology, Others

What are the Type segmentation covered in the Pharmaceutical CDMO and Contract Manufacturing Services Market report?

Ans: The Types covered in the Pharmaceutical CDMO and Contract Manufacturing Services Market report are Drug Development, API production

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Development
1.2.3 API production
1.3 Market by Application
1.3.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharma Industry
1.3.3 Biotechnology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Perspective (2020-2031)
2.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Growth Trends by Region
2.2.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical CDMO and Contract Manufacturing Services Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical CDMO and Contract Manufacturing Services Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical CDMO and Contract Manufacturing Services Market Dynamics
2.3.1 Pharmaceutical CDMO and Contract Manufacturing Services Industry Trends
2.3.2 Pharmaceutical CDMO and Contract Manufacturing Services Market Drivers
2.3.3 Pharmaceutical CDMO and Contract Manufacturing Services Market Challenges
2.3.4 Pharmaceutical CDMO and Contract Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CDMO and Contract Manufacturing Services Players by Revenue
3.1.1 Global Top Pharmaceutical CDMO and Contract Manufacturing Services Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical CDMO and Contract Manufacturing Services Revenue
3.4 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO and Contract Manufacturing Services Revenue in 2024
3.5 Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services Head office and Area Served
3.6 Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services, Product and Application
3.7 Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CDMO and Contract Manufacturing Services Breakdown Data by Type
4.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical CDMO and Contract Manufacturing Services Breakdown Data by Application
5.1 Global Pharmaceutical CDMO and Contract Manufacturing Services Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical CDMO and Contract Manufacturing Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2020-2031)
6.2 North America Pharmaceutical CDMO and Contract Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025)
6.4 North America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2020-2031)
7.2 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2020-2031)
9.2 Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Haixiang Pharmaceutical
11.1.1 Haixiang Pharmaceutical Company Details
11.1.2 Haixiang Pharmaceutical Business Overview
11.1.3 Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.1.4 Haixiang Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.1.5 Haixiang Pharmaceutical Recent Development
11.2 Innovent Biologics
11.2.1 Innovent Biologics Company Details
11.2.2 Innovent Biologics Business Overview
11.2.3 Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.2.4 Innovent Biologics Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.2.5 Innovent Biologics Recent Development
11.3 Betta Pharmaceuticals
11.3.1 Betta Pharmaceuticals Company Details
11.3.2 Betta Pharmaceuticals Business Overview
11.3.3 Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.3.4 Betta Pharmaceuticals Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.3.5 Betta Pharmaceuticals Recent Development
11.4 Jiuzhou Pharmaceutical
11.4.1 Jiuzhou Pharmaceutical Company Details
11.4.2 Jiuzhou Pharmaceutical Business Overview
11.4.3 Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.4.4 Jiuzhou Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.4.5 Jiuzhou Pharmaceutical Recent Development
11.5 Puluo Pharmaceutical
11.5.1 Puluo Pharmaceutical Company Details
11.5.2 Puluo Pharmaceutical Business Overview
11.5.3 Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.5.4 Puluo Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.5.5 Puluo Pharmaceutical Recent Development
11.6 Menohua
11.6.1 Menohua Company Details
11.6.2 Menohua Business Overview
11.6.3 Menohua Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.6.4 Menohua Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.6.5 Menohua Recent Development
11.7 Tianyu shares
11.7.1 Tianyu shares Company Details
11.7.2 Tianyu shares Business Overview
11.7.3 Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.7.4 Tianyu shares Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.7.5 Tianyu shares Recent Development
11.8 Aoxiang Pharmaceutical
11.8.1 Aoxiang Pharmaceutical Company Details
11.8.2 Aoxiang Pharmaceutical Business Overview
11.8.3 Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.8.4 Aoxiang Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.8.5 Aoxiang Pharmaceutical Recent Development
11.9 Hetero
11.9.1 Hetero Company Details
11.9.2 Hetero Business Overview
11.9.3 Hetero Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.9.4 Hetero Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.9.5 Hetero Recent Development
11.10 CellMark
11.10.1 CellMark Company Details
11.10.2 CellMark Business Overview
11.10.3 CellMark Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.10.4 CellMark Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.10.5 CellMark Recent Development
11.11 R&D Systems
11.11.1 R&D Systems Company Details
11.11.2 R&D Systems Business Overview
11.11.3 R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.11.4 R&D Systems Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.11.5 R&D Systems Recent Development
11.12 Porton Pharmaceuticals
11.12.1 Porton Pharmaceuticals Company Details
11.12.2 Porton Pharmaceuticals Business Overview
11.12.3 Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.12.4 Porton Pharmaceuticals Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.12.5 Porton Pharmaceuticals Recent Development
11.13 Kai Laiying
11.13.1 Kai Laiying Company Details
11.13.2 Kai Laiying Business Overview
11.13.3 Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.13.4 Kai Laiying Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.13.5 Kai Laiying Recent Development
11.14 Smart Life
11.14.1 Smart Life Company Details
11.14.2 Smart Life Business Overview
11.14.3 Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.14.4 Smart Life Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.14.5 Smart Life Recent Development
11.15 Notai Biotech
11.15.1 Notai Biotech Company Details
11.15.2 Notai Biotech Business Overview
11.15.3 Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.15.4 Notai Biotech Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.15.5 Notai Biotech Recent Development
11.16 Aurobindo Pharma
11.16.1 Aurobindo Pharma Company Details
11.16.2 Aurobindo Pharma Business Overview
11.16.3 Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.16.4 Aurobindo Pharma Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.16.5 Aurobindo Pharma Recent Development
11.17 Lonza Group
11.17.1 Lonza Group Company Details
11.17.2 Lonza Group Business Overview
11.17.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.17.4 Lonza Group Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.17.5 Lonza Group Recent Development
11.18 Catalent Inc.
11.18.1 Catalent Inc. Company Details
11.18.2 Catalent Inc. Business Overview
11.18.3 Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.18.4 Catalent Inc. Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.18.5 Catalent Inc. Recent Development
11.19 Recipharm AB
11.19.1 Recipharm AB Company Details
11.19.2 Recipharm AB Business Overview
11.19.3 Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.19.4 Recipharm AB Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.19.5 Recipharm AB Recent Development
11.20 Jubilant Pharmova Ltd
11.20.1 Jubilant Pharmova Ltd Company Details
11.20.2 Jubilant Pharmova Ltd Business Overview
11.20.3 Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.20.4 Jubilant Pharmova Ltd Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.20.5 Jubilant Pharmova Ltd Recent Development
11.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
11.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Company Details
11.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
11.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development
11.22 Boehringer Ingelheim Group
11.22.1 Boehringer Ingelheim Group Company Details
11.22.2 Boehringer Ingelheim Group Business Overview
11.22.3 Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.22.4 Boehringer Ingelheim Group Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.22.5 Boehringer Ingelheim Group Recent Development
11.23 Pfizer CentreSource
11.23.1 Pfizer CentreSource Company Details
11.23.2 Pfizer CentreSource Business Overview
11.23.3 Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.23.4 Pfizer CentreSource Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.23.5 Pfizer CentreSource Recent Development
11.24 Baxter International Inc.
11.24.1 Baxter International Inc. Company Details
11.24.2 Baxter International Inc. Business Overview
11.24.3 Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.24.4 Baxter International Inc. Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.24.5 Baxter International Inc. Recent Development
11.25 Lonza Group
11.25.1 Lonza Group Company Details
11.25.2 Lonza Group Business Overview
11.25.3 Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Introduction
11.25.4 Lonza Group Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
11.25.5 Lonza Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Haixiang Pharmaceutical
Innovent Biologics
Betta Pharmaceuticals
Jiuzhou Pharmaceutical
Puluo Pharmaceutical
Menohua
Tianyu shares
Aoxiang Pharmaceutical
Hetero
CELLMARK
R&D Systems
Porton Pharmaceuticals
Kai Laiying
Smart Life
Notai Biotech
Aurobindo Pharma
Catalent
Recipharm
Jubilant Pharmova Ltd.
Patheon Inc. (Thermo Fisher Scientific Inc.)
Boehringer Ingelheim group
Pfizer CentreSource
Baxter International Inc
List of Tables
 Table 1. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drug Development
 Table 3. Key Players of API production
 Table 4. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Region (2020-2025)
 Table 8. Global Pharmaceutical CDMO and Contract Manufacturing Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Region (2026-2031)
 Table 10. Pharmaceutical CDMO and Contract Manufacturing Services Market Trends
 Table 11. Pharmaceutical CDMO and Contract Manufacturing Services Market Drivers
 Table 12. Pharmaceutical CDMO and Contract Manufacturing Services Market Challenges
 Table 13. Pharmaceutical CDMO and Contract Manufacturing Services Market Restraints
 Table 14. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Players (2020-2025)
 Table 16. Global Top Pharmaceutical CDMO and Contract Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO and Contract Manufacturing Services as of 2024)
 Table 17. Ranking of Global Top Pharmaceutical CDMO and Contract Manufacturing Services Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmaceutical CDMO and Contract Manufacturing Services Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services, Headquarters and Area Served
 Table 20. Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services, Product and Application
 Table 21. Global Key Players of Pharmaceutical CDMO and Contract Manufacturing Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmaceutical CDMO and Contract Manufacturing Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmaceutical CDMO and Contract Manufacturing Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmaceutical CDMO and Contract Manufacturing Services Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Haixiang Pharmaceutical Company Details
 Table 47. Haixiang Pharmaceutical Business Overview
 Table 48. Haixiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 49. Haixiang Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 50. Haixiang Pharmaceutical Recent Development
 Table 51. Innovent Biologics Company Details
 Table 52. Innovent Biologics Business Overview
 Table 53. Innovent Biologics Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 54. Innovent Biologics Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 55. Innovent Biologics Recent Development
 Table 56. Betta Pharmaceuticals Company Details
 Table 57. Betta Pharmaceuticals Business Overview
 Table 58. Betta Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 59. Betta Pharmaceuticals Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 60. Betta Pharmaceuticals Recent Development
 Table 61. Jiuzhou Pharmaceutical Company Details
 Table 62. Jiuzhou Pharmaceutical Business Overview
 Table 63. Jiuzhou Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 64. Jiuzhou Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 65. Jiuzhou Pharmaceutical Recent Development
 Table 66. Puluo Pharmaceutical Company Details
 Table 67. Puluo Pharmaceutical Business Overview
 Table 68. Puluo Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 69. Puluo Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 70. Puluo Pharmaceutical Recent Development
 Table 71. Menohua Company Details
 Table 72. Menohua Business Overview
 Table 73. Menohua Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 74. Menohua Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 75. Menohua Recent Development
 Table 76. Tianyu shares Company Details
 Table 77. Tianyu shares Business Overview
 Table 78. Tianyu shares Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 79. Tianyu shares Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 80. Tianyu shares Recent Development
 Table 81. Aoxiang Pharmaceutical Company Details
 Table 82. Aoxiang Pharmaceutical Business Overview
 Table 83. Aoxiang Pharmaceutical Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 84. Aoxiang Pharmaceutical Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 85. Aoxiang Pharmaceutical Recent Development
 Table 86. Hetero Company Details
 Table 87. Hetero Business Overview
 Table 88. Hetero Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 89. Hetero Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 90. Hetero Recent Development
 Table 91. CellMark Company Details
 Table 92. CellMark Business Overview
 Table 93. CellMark Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 94. CellMark Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 95. CellMark Recent Development
 Table 96. R&D Systems Company Details
 Table 97. R&D Systems Business Overview
 Table 98. R&D Systems Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 99. R&D Systems Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 100. R&D Systems Recent Development
 Table 101. Porton Pharmaceuticals Company Details
 Table 102. Porton Pharmaceuticals Business Overview
 Table 103. Porton Pharmaceuticals Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 104. Porton Pharmaceuticals Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 105. Porton Pharmaceuticals Recent Development
 Table 106. Kai Laiying Company Details
 Table 107. Kai Laiying Business Overview
 Table 108. Kai Laiying Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 109. Kai Laiying Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 110. Kai Laiying Recent Development
 Table 111. Smart Life Company Details
 Table 112. Smart Life Business Overview
 Table 113. Smart Life Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 114. Smart Life Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 115. Smart Life Recent Development
 Table 116. Notai Biotech Company Details
 Table 117. Notai Biotech Business Overview
 Table 118. Notai Biotech Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 119. Notai Biotech Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 120. Notai Biotech Recent Development
 Table 121. Aurobindo Pharma Company Details
 Table 122. Aurobindo Pharma Business Overview
 Table 123. Aurobindo Pharma Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 124. Aurobindo Pharma Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 125. Aurobindo Pharma Recent Development
 Table 126. Lonza Group Company Details
 Table 127. Lonza Group Business Overview
 Table 128. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 129. Lonza Group Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 130. Lonza Group Recent Development
 Table 131. Catalent Inc. Company Details
 Table 132. Catalent Inc. Business Overview
 Table 133. Catalent Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 134. Catalent Inc. Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 135. Catalent Inc. Recent Development
 Table 136. Recipharm AB Company Details
 Table 137. Recipharm AB Business Overview
 Table 138. Recipharm AB Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 139. Recipharm AB Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 140. Recipharm AB Recent Development
 Table 141. Jubilant Pharmova Ltd Company Details
 Table 142. Jubilant Pharmova Ltd Business Overview
 Table 143. Jubilant Pharmova Ltd Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 144. Jubilant Pharmova Ltd Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 145. Jubilant Pharmova Ltd Recent Development
 Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Company Details
 Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Business Overview
 Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 150. Patheon Inc. (Thermo Fisher Scientific Inc.) Recent Development
 Table 151. Boehringer Ingelheim Group Company Details
 Table 152. Boehringer Ingelheim Group Business Overview
 Table 153. Boehringer Ingelheim Group Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 154. Boehringer Ingelheim Group Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 155. Boehringer Ingelheim Group Recent Development
 Table 156. Pfizer CentreSource Company Details
 Table 157. Pfizer CentreSource Business Overview
 Table 158. Pfizer CentreSource Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 159. Pfizer CentreSource Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 160. Pfizer CentreSource Recent Development
 Table 161. Baxter International Inc. Company Details
 Table 162. Baxter International Inc. Business Overview
 Table 163. Baxter International Inc. Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 164. Baxter International Inc. Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 165. Baxter International Inc. Recent Development
 Table 166. Lonza Group Company Details
 Table 167. Lonza Group Business Overview
 Table 168. Lonza Group Pharmaceutical CDMO and Contract Manufacturing Services Product
 Table 169. Lonza Group Revenue in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025) & (US$ Million)
 Table 170. Lonza Group Recent Development
 Table 171. Research Programs/Design for This Report
 Table 172. Key Data Information from Secondary Sources
 Table 173. Key Data Information from Primary Sources
 Table 174. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical CDMO and Contract Manufacturing Services Picture
 Figure 2. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Type: 2024 VS 2031
 Figure 4. Drug Development Features
 Figure 5. API production Features
 Figure 6. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Application: 2024 VS 2031
 Figure 8. Pharma Industry Case Studies
 Figure 9. Biotechnology Case Studies
 Figure 10. Others Case Studies
 Figure 11. Pharmaceutical CDMO and Contract Manufacturing Services Report Years Considered
 Figure 12. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Region: 2024 VS 2031
 Figure 15. Global Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Players in 2024
 Figure 16. Global Top Pharmaceutical CDMO and Contract Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO and Contract Manufacturing Services as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO and Contract Manufacturing Services Revenue in 2024
 Figure 18. North America Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Country (2020-2031)
 Figure 20. United States Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Country (2020-2031)
 Figure 24. Germany Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Region (2020-2031)
 Figure 32. China Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Country (2020-2031)
 Figure 40. Mexico Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharmaceutical CDMO and Contract Manufacturing Services Market Share by Country (2020-2031)
 Figure 44. Turkey Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Pharmaceutical CDMO and Contract Manufacturing Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Haixiang Pharmaceutical Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 48. Innovent Biologics Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 49. Betta Pharmaceuticals Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 50. Jiuzhou Pharmaceutical Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 51. Puluo Pharmaceutical Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 52. Menohua Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 53. Tianyu shares Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 54. Aoxiang Pharmaceutical Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 55. Hetero Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 56. CellMark Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 57. R&D Systems Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 58. Porton Pharmaceuticals Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 59. Kai Laiying Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 60. Smart Life Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 61. Notai Biotech Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 62. Aurobindo Pharma Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 63. Lonza Group Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 64. Catalent Inc. Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 65. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 66. Jubilant Pharmova Ltd Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 67. Patheon Inc. (Thermo Fisher Scientific Inc.) Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 68. Boehringer Ingelheim Group Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 69. Pfizer CentreSource Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 70. Baxter International Inc. Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 71. Lonza Group Revenue Growth Rate in Pharmaceutical CDMO and Contract Manufacturing Services Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions